Screening - inclusion criteria

Similar documents
Screening - inclusion criteria

Screening - inclusion criteria

GUIDELINEs ON PAIN MANAGEMENT IN UROLOGY

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

eappendix A. Opioids and Nonsteroidal Anti-Inflammatory Drugs

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

GUIDELINEs ON PAIN MANAGEMENT IN UROLOGY

Post-caesarean analgesia. Genevieve Goulding Royal Brisbane & Women's Hospital 1

problems with, 29, 98 psychiatric patients, 96 rheumatic conditions, 97

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

Appendix A: Pharmacologic approaches to pain management during MVA

Learning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16

PAIN MANAGEMENT IN UROLOGY

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

GUIDELINES ON PAIN MANAGEMENT IN UROLOGY

CHAPTER 4 PAIN AND ITS MANAGEMENT

Post Caesarean Analgesia An Update. Kim Ekelund MD, PhD, associate professor Rigshospitalet Copenhagen, Denmark

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital

Paediatric Anaesthesia Formulas

WORRIED ABOUT PAIN AFTER ORAL SURGERY?

Analgesia for ERAS programs. Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital

Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation

Single-shot block for elective shoulder surgery Is it enough? Mr C Watkins, Miss L Onwordi Mr J Chakravarthy, Dr A Gupta. NESRA annual meeting 2016

Regional Anaesthesia for Children

Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine

THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT

STARTER PACK: Webinar #1 ADE4 - OPIOIDS

Inpatient Management of Trauma Related Pain

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Acute Peri-Operative Pain Management Strategies

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

The Fifth Vital Sign.

Analgesia in patients with impaired renal function Formulary Guidance

NYSPFP Kickoff. Reducing Adverse Drug Events from Opioids. April 6, 2017

Peri operative pain control. Disclosure. Objectives 9/1/2011. No current conflicts of interest

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

9/30/2017. Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management. Program Objectives. Impact of Poorly Managed Pain

Measure Abbreviation: PONV 01 (MIPS 430)

disease or in clients who consume alcohol on a regular basis. bilirubin

Measure Abbreviation: PONV 01 (MIPS 430)

Neck Pain. Frank Thomas BSc(Hons) MBChB FANZCA FFPMANZCA

5 MUSCULOSKELETAL SYSTEM

Postoperative Pain Management. Nimmaanrat S, MD, FRCAT, MMed (Pain Mgt)

BJF Acute Pain Team Formulary Group

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS

Mr David A McDonald Service Improvement Manager Whole System patient Flow Improvement Programme Scottish Government

2018 Learning Outcomes

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

DEPARTMENT OF ANESTHESIOLOGY JOURNAL CLUB. Tuesday October 14, HOURS. LOCATION: The Rivermill 2 Cataraqui Street

OAA Survey 156: Current prescribing practices for post-operative analgesia following emergency and elective LSCS

What s New 2003? What new treatments? What have you discontinued? More information please!

Pain Assessment & Management. For General Nursing Orientation

Acute Pain NETP: SEPTEMBER 2013 COHORT

CHAPTER 4 PAIN AND ITS MANAGEMENT

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

Gabapentin Does Not Improve Analgesia Outcomes For Total Joint Replacement. Manyat Nantha-Aree, MD

Knock Out Opioid Abuse in New Jersey:

10/08/59 PAIN IS THE MOST COMMON TREATABLE SYMPTOM OF CANCER CURRENT EVIDENCE BASED CONCEPTS: MANAGEMENT OF CANCER PAIN PAIN AN UNMET CLINICAL NEED IN

Opioid Capture in the AHSQC Can we reduce use by measuring it? Michael Reinhorn MD, MBA, FACS Dept of Surgery, Newton Wellesley Hospital

PAIN PODCAST SHOW NOTES:

EPIDURAL / INTRATHECAL POST-OP PLAN

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Measure Summary: The opioid equivalency measure examines opioid administration for patients who undergo a surgical procedure.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Subject: Pain Management (Page 1 of 7)

Supplemental Digital Content 2. Data Collection Questionnaires, Variables, and Definitions

Parecoxib, Celecoxib and Paracetamol for Post Caesarean Analgesia: A Randomised Controlled Trial

No Pain, No Gain Pharmacy Patient Pain Counseling Competition

Summary of risk management plan for Dzuveo (Sufentanil (as citrate))

NSAIDs and Tonsillectomy: Efficacy for Pain Relief

Role and safety of epidural analgesia

Oral Pain Medications in Your Practice Scot Morris, OD, FAAO

Awake regional versus general anesthesia in preterms and ex-preterm infants for herniotomy

May, Million Prescriptions: What we know about the growing use of prescription opioids in Ontario. Technical Appendix

Turlough O Hare, MD, FRCPC, MSc Assistant Clinical Professor, Department of Anesthesia, St. Joseph s Healthcare Hamilton McMaster University

PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE?

Session II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids

Palliative Prescribing - Pain

BACKGROUND Measuring renal function :

Objectives. Conflict of Interest Disclosure. Neuraxial and Regional Anesthesia in the Pediatric Population

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective

Pain management following your operation

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

1

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

EUROANESTHESIA 2008 Copenhagen, Denmark, 31 May - 3 June RC1

ERAS: Enhanced Recovery After Surgery. Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland

Original Date of issue: 01/11/2005 Last Reviewed: 01/05/2011 Version:4 Page 1 of 7

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Narcotic Analgesics. Jacqueline Morgan March 22, 2017

Effective Postoperative Pain Management for Children. Nancy L. Glass, MD, MBA,

Care in the Last Days of Life

Transcription:

A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Patient code (local): Room number: Screening - inclusion criteria yes no S1 Time of data collection is POD1 AND patient is 6 hrs (minimum) in the ward End surgery: Date: 2 0 1 Y M M D D Time: H H M M POD1? Back in ward: Date: 2 0 1 Y M M D D Time: H H M M 6hrs? S2 Patient is consenting age or over S3 Patient has given his assent (or consent) to participate If no to S3, mark the reason(s): a. Patient is not on the ward b. Patient does not wish to participate 1 b1. too ill b2. too much pain b3. other c. Patient is asleep d. Patient has visitors e. It is not possible to communicate with the patient (e.g., patient is deaf, does not read/write in any of the languages in which the Outcomes questionnaire is available) f. Patient is cognitively impaired (e.g., Downs syndrome, dementia, Alzheimer s disease, Cerebral Palsy) g. If yes to 1 and 2 and 3 Give the Outcomes questionnaire to the patient Complete the Process questionnaire If no to 1 or 2 or 3: Do not fill in the rest of the Process questionnaire Do not give the Outcomes questionnaire to the patient Input the screening data (up to the point you have reached) into the web mask Special case: If yes to 1 and 2 and 3f and you have permission from the Ethics Committee in your hospital: Complete the Process questionnaire 1 Remember: You may interview patients who need help, e.g., are too ill or in too much pain or illiterate Demographic information D1 Gender Male Female D2 Year of birth Y Y D3 Weight kg D4 Height cm D5 Nationality (check records) D6 Country of birth (check records) D7 Language of Outcome questionnaire (select one) Albanian Arabic Bahasa Malaysia Danish Dutch English Filipino Finnish French German Hebrew Hindustani Icelandic Italian Korean Mandarin Romanian Russian Serbo-Croatian Spanish Span. Mexico Swedish Blank Fields Blank field 1: Blank field 5: Blank field 2: Blank field 6: Blank field 3: Blank field 7: Blank field 4: Project phase: Version2.8 2018-Apr-18

Page 2 Medical history H1 Comorbidities Cancer Cancer Renal Renal insufficiency or disease without dialysis Renal disease requiring dialysis Diabetes diabetes Type I Diabetes Type II Diabetes Type unknown Psychiatric Affective disorders (depression, anxiety, phobia, PTSD, bipolar disorder) Schizophrenia Alcohol use disorder Current smoker Substance abuse of drugs (legal and illegal) Cardiovascular Hypertension Coronary artery disease or myocardial infarction or cerebral vascular accident Hematology Sickle cell disease GI disease Liver Cirrhosis History or current upper or lower GI ulcer (peptic or duodenal ulcer disease) Irritable bowel disease (Crohn s disease, ulcerative colitis) Pulmonary disease Asthma Sleep apnea Chronic Obstructive Pulmonary Disease (COPD) Neurologic Fibromyalgia Steroid use Regular administration of oral or parenteral corticosteroid medications Multiple trauma At least 1 fracture(s) / laceration(s) / tissue damage in addition to the current reason for surgery Other surgery Patient has already undergone another surgery during current hospitalization H2 Existing condition (check medical record) Pregnancy, Week: not relevant not possible to obtain the information Lactation not relevant not possible to obtain the information H3 Did the patient receive any opioid(s) before the current admission? Immediate Buprenorphine mg\day Controlled ; transdermal Codeine mg\day mg\day Fentanyl transmucosal / intranasal transdermal Hydrocodone mg\day mg\day Hydromorphone mg\day mg\day Morphine mg\day mg\day Oxycodone mg\day mg\day Oxycodone (with Naloxon) mg\day mg\day Pethidine (Meperidine) mg\day mg\day Tapentadol mg\day mg\day Tilidin (w\wo Naloxon) mg\day mg\day Tramadol mg\day mg\day

Page 3 : Pre - medication M1 Sedatives (pre-medication) p.o. i.v. Diazepam mg mg Clorazepate dipotassium mg mg Haloperidol mg mg Lorazepam mg mg Midazolam mg mg Promethazine mg mg mg mg M2 Non-opioids (pre-medication) p.o. i.v. i.m. supp. Celecoxib mg mg mg mg Dexamethasone mg mg mg mg Dexketoprofen mg mg mg mg Diclofenac mg mg mg mg Etoricoxib mg mg mg mg Gabapentin mg mg mg mg Ibuprofen mg mg mg mg Ketoprofen mg mg mg mg Ketorolac mg mg mg mg Metamizol mg mg mg mg Naproxen mg mg mg mg Nefopam mg mg mg mg Paracetamol (Acetaminophen) mg mg mg mg Parecoxib mg mg mg mg Pregabalin mg mg mg mg

Page 4 : Pre - medication M3 Opioids (pre-medication) Immediate Controlled i.v. i.m. supp. s.c. Buprenorphine mg µg µg µg µg Codeine mg mg mg mg mg mg Fentanyl µg transmucosal transdermal µg µg µg µg Hydrocodone mg mg mg mg mg mg Hydromorphone mg mg mg mg mg mg Morphine mg mg mg mg mg mg Nalbuphine mg mg mg mg mg mg Oxycodone mg mg mg mg mg mg Oxycodone (with Naloxon) mg mg mg mg mg mg Pethidine (Meperidine) mg mg mg mg mg mg Piritramide mg mg mg mg mg mg Sufentanil µg µg µg µg µg µg Tapentadol mg mg mg mg mg mg Tilidin (w\wo Naloxon) mg mg mg mg mg mg Tramadol mg mg mg mg mg mg Surgical procedure(s) P1 Surgical procedure(s) use ICD-9 codes link http://icd9cm.chrisendres.com/index.php?action=procslist ICD-9 Procedure Code 1 1 2 2 3 3 4 4 Text (only for your notes, not necessary for mask) P2 Duration of surgery Start surgery: Date: 2 0 1 Y M M D D Time: H H M M End surgery: Date: 2 0 1 Y M M D D Time: H H M M Version2.5 101119

Page 5 M3 Opioids (pre-medication) Intra-operative M4 General anaesthesia (intra-op) Inhalational IV M5 Regional anaesthesia (RA) (intra-op) Epidural Spinal Brachial plexus Femoral Sciatic Paravertebral Other: Other: In M8: Mark the RA medication(s) given in the RA column M6 Non-opioids (intra-op) If yes, which (multiple answers possible): i.v. i.m. supp. Clonidine mg mg mg Decamethasone mg mg mg Dexketoprofen mg mg mg Diclofenac mg mg mg Ibuprofen mg mg mg Ketamine mg mg mg Ketoprofen mg mg mg Ketorolac mg mg mg Metamizol mg mg mg Naproxen mg mg mg Nefopam mg mg mg Paracetamol (Acetaminophen) mg mg mg Parecoxib mg mg mg i.v. i.m. supp.

Page 6 Intra-op M7 Wound infiltration (intra-op) yes no not possible to obtain the information If yes, which (multiple answers possible; analgesic is not recorded): Single shot by surgeon Indwelling catheter M8 Opioids & local anaesthetics (intra-op) RA (see M5) i.v. i.m. s.c. Alfentanil mg mg mg mg Buprenorphine µg µg µg µg Codeine mg mg mg mg Fentanyl µg µg µg µg Hydrocodone mg mg mg mg Hydromorphone mg mg mg mg Morphine mg mg mg mg Nalbuphin mg mg mg mg Oxycodone mg mg mg mg Pethidine (Meperidine) mg mg mg mg Piritramid mg mg mg mg Remifentanil mg mg mg mg Sufentanil µg µg µg µg Tramadol mg mg mg mg Bupivacaine Levobupivacaine Lidocaine Prilocaine Ropivacaine RA i.v. i.m. s.c.

Page 7 Recovery Room M9 Non-opioids (recovery room) p.o. i.v. i.m. supp. Celecoxib mg mg mg mg Clonidine mg mg mg mg Dexamethasone mg mg mg mg Dexketoprofen mg mg mg mg Diclofenac mg mg mg mg Etoricoxib mg mg mg mg Gabapentin mg mg mg mg Ibuprofen mg mg mg mg Ketamine mg mg mg mg Ketoprofen mg mg mg mg Ketorolac mg mg mg mg Metamizol mg mg mg mg Naproxen mg mg mg mg Nefopam mg mg mg mg Paracetamol (Acetaminophen) mg mg mg mg Parecoxib mg mg mg mg Pregabalin mg mg mg mg p.o. i.v. i.m. supp. M10 Regional analgesia (recovery room) Epidural Spinal Brachial plexus Femoral Sciatic Paravertebral Other: Other: In M11: (1) Mark the RA medication(s) given in the RA column (2) If the medication was given as PCA, tick appropriate box in the PCA column

Page 8 Recovery room M11 Opioids & local anaesthetics (recovery room) Immediate Controlled RA (see M10) i.v. i.m. supp. s.c. PCA (see M10) Buprenorphine mg µg µg µg µg µg Codeine mg mg mg mg mg mg mg Fentanyl µg transmucosal transdermal µg µg µg µg µg Hydrocodone mg mg mg mg mg mg mg Hydromorphone mg mg mg mg mg mg mg Morphine mg mg mg mg mg mg mg Nalbuphin mg mg mg mg mg mg mg Oxycodone mg mg mg mg mg mg mg Oxycodone (with Naloxone) mg mg mg mg mg mg mg Pethidine (Meperidine) mg mg mg mg mg mg mg Piritramid mg mg mg mg mg mg mg Sufentanil µg µg µg µg µg µg µg Tapentadol mg mg mg mg mg mg mg Tilidin (w\wo Naloxon) mg mg mg mg mg mg mg Tramadol mg mg mg mg mg mg mg Bupivacaine Levobupivacaine Lidocaine Prilocaine Ropivacaine Naloxone (only as an antagonist for respiratory depression) Immediate mg mg mg mg mg mg mg Controlled RA i.v. i.m. supp. s.c. PCA Version2.6 140213

Page 9 Ward M12 Non-opioids (ward) p.o. i.v. i.m. supp. Celecoxib mg mg mg mg Clonidine mg mg mg mg Dexamethasone mg mg mg mg Dexketoprofen mg mg mg mg Diclofenac mg mg mg mg Etoricoxib mg mg mg mg Gabapentin mg mg mg mg Ibuprofen mg mg mg mg WARD Ketamine mg mg mg mg Ketoprofen mg mg mg mg Ketorolac mg mg mg mg Metamizol mg mg mg mg Naproxen mg mg mg mg Nefopam mg mg mg mg Paracetamol (Acetaminophen) mg mg mg mg Parecoxib mg mg mg mg Pregabalin mg mg mg mg M13 Regional analgesia (ward) Epidural Spinal Brachial plexus Femoral Sciatic Paravertebral Other: Other: In M14: (1) Mark the RA medication(s) given in the RA column (2) If the medication was given as PCA, tick appropriate box in the PCA column Version2.6 140213

Page 10 WARD M14 Opioids & local anaesthetics (ward) Immediate Controlled RA (see M13) i.v. i.m. supp. s.c. PCA (see M13) Buprenorphine mg µg µg µg µg Codeine mg mg mg mg mg mg mg Fentanyl µg transmucosal transdermal µg µg µg µg µg µg Hydrocodone mg mg mg mg mg mg mg Hydromorphone mg mg mg mg mg mg mg Morphine mg mg mg mg mg mg mg Nalbuphin mg mg mg mg mg mg mg Oxycodone mg mg mg mg mg mg mg Oxycodone (with Naloxone) mg mg mg mg mg mg mg Pethidine (Meperidine) mg mg mg mg mg mg mg Piritramid mg mg mg mg mg mg mg Sufentanil µg µg µg µg µg µg µg Tapentadol mg mg mg mg mg mg mg Tilidin (w\wo Naloxon) mg mg mg mg mg mg mg Tramadol mg mg mg mg mg mg mg Bupivacaine Levobupivacaine Lidocaine Prilocaine Ropivacaine Naloxone (only as an antagonist for respiratory depression) mg mg mg mg mg mg mg M15 Measurement of pain: Was pain documented as defined in the SOPs? yes no not possible to obtain the information M16 New PCA techniques (ward) Sufentanil (Zalviso) yes µg no not possible to obtain the information